3D modeling before lung surgery to predict lung function
Part of Cancer, Lungs & breathing clinical trials.
This trial uses 3D models from your CT scan to help doctors predict how well your lungs will work after surgery. It is for people having a certain type of lung surgery (VATS) to remove part of a lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You are scheduled for VATS lobectomy or segmentectomy at National Taiwan University Hospital or NTU Cancer Center.
- You can sign a consent form to let researchers use your imaging data.
- You do not have Chronic Obstructive Pulmonary Disease (COPD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether 3D models from a CT scan without dye can help guide minimally invasive lung surgery. If you have a small early-stage lung cancer and are eligible for keyhole surgery, this study might be for you.
This study tests if using a personalized 3D model of your lung before surgery helps you better understand the procedure and make decisions. It is for people scheduled for keyhole lung surgery for a tumor.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
This study looks at how well your lungs work after surgery for lung cancer. It uses special scans and breathing tests to help doctors better predict your recovery.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.